Skip to main content

Logos Global Management LP

SEC CIK
0001792126
Latest filing
Aug 14, 2026

DNTH holding history

Dianthus Therapeutics, Inc. in every 13F filed by Logos Global Management LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DNTH overviewAll 13F holders of DNTHFull Q2 2026 holdings

Shares (Q2 2026)
800,000
Value
$78.0M
% of portfolio
3.4%
Quarters held
4
Since Q3 2025
Holdings of DNTH by Logos Global Management LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026800,000$78.0M3.4%+400,000+100.0%AddedHolders
Q1 2026400,000$33.6M1.7%+85,000+27.0%AddedHolders
Q4 2025315,000$13.0M0.9%+115,000+57.5%AddedHolders
Q3 2025200,000$7.87M0.8%+200,000NewHolders